KORU Medical Systems (NASDAQ:KRMD) Price Target Raised to $5.00 at Craig Hallum

KORU Medical Systems (NASDAQ:KRMD) had its price objective boosted by Craig Hallum from $4.00 to $5.00 in a report released on Thursday morning,Benzinga reports. They currently have a buy rating on the stock.

A number of other analysts have also weighed in on the stock. Piper Sandler upped their price objective on shares of KORU Medical Systems from $3.00 to $3.50 and gave the stock an “overweight” rating in a research note on Thursday. B. Riley started coverage on shares of KORU Medical Systems in a research note on Thursday, July 25th. They issued a “buy” rating and a $4.00 price objective for the company. Finally, Canaccord Genuity Group upped their price objective on shares of KORU Medical Systems from $3.00 to $4.00 and gave the stock a “buy” rating in a research note on Thursday.

KORU Medical Systems Trading Up 2.9 %

KRMD stock traded up $0.09 during mid-day trading on Thursday, reaching $3.17. 55,159 shares of the stock traded hands, compared to its average volume of 114,489. The company has a debt-to-equity ratio of 0.01, a quick ratio of 3.27 and a current ratio of 3.77. KORU Medical Systems has a one year low of $1.98 and a one year high of $3.40. The stock has a market capitalization of $145.34 million, a PE ratio of -12.48 and a beta of 0.41. The business has a 50-day moving average price of $2.65 and a two-hundred day moving average price of $2.47.

Institutional Investors Weigh In On KORU Medical Systems

A number of institutional investors have recently added to or reduced their stakes in KRMD. Connor Clark & Lunn Investment Management Ltd. lifted its holdings in KORU Medical Systems by 77.7% in the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 61,412 shares of the company’s stock valued at $168,000 after purchasing an additional 26,860 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. purchased a new position in KORU Medical Systems in the 2nd quarter valued at $107,000. Meros Investment Management LP raised its holdings in shares of KORU Medical Systems by 20.7% during the 2nd quarter. Meros Investment Management LP now owns 804,380 shares of the company’s stock worth $2,132,000 after acquiring an additional 137,918 shares during the period. Legato Capital Management LLC purchased a new position in shares of KORU Medical Systems during the 2nd quarter worth $35,000. Finally, Allspring Global Investments Holdings LLC purchased a new position in shares of KORU Medical Systems during the 2nd quarter worth $28,000. Institutional investors and hedge funds own 58.60% of the company’s stock.

About KORU Medical Systems

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.